| Literature DB >> 29501406 |
Makoto Nishioka1, Yuji Inaba2, Mitsuo Motobayashi3, Yosuke Hara1, Ryusuke Numata4, Yoshiro Amano4, Kunihiko Shingu5, Yoichiro Yamamoto6, Kei Murayama7, Akira Ohtake8, Yozo Nakazawa1.
Abstract
INTRODUCTION: Mitochondrial dysfunction results in a wide range of organ disorders through diverse genetic abnormalities. We herein present the detailed clinical course of an infant admitted for extensive, rapidly progressing white matter lesions and hypertrophic cardiomyopathy due to a BOLA3 gene mutation. CASE: A 6-month-old girl with no remarkable family or past medical history until 1 month prior presented with developmental regression and feeding impairment. Ultrasound cardiography and brain magnetic resonance imaging (MRI) respectively disclosed the presence of hypertrophic cardiomyopathy and symmetrical deep white matter lesions. She was transferred to our hospital at age 6 months. High lactate levels in her cerebrospinal fluid suggested mitochondrial dysfunction. Despite vitamin supplementation therapy followed by a ketogenic diet, the patient began exhibiting clusters of myoclonic seizures and respiratory failure. Brain and spinal cord MRI revealed rapid progression of the white matter lesions. She died at 10 months of age. Fibroblasts obtained pre-mortem displayed low mitochondrial respiratory chain complex I and II activity. A homozygous H96R (c. 287 A > G) mutation was identified in the BOLA3 gene. DISCUSSION: No reported case of a homozygous BOLA3 gene mutation has survived past 1 year of life. BOLA3 appears to play a critical role in the electron transport system and production of iron-sulfur clusters that are related to lipid metabolism and enzyme biosynthesis.Entities:
Keywords: BOLA3 gene; Cardiomyopathy; Encephalopathy; Magnetic resonance imaging; Mitochondrial respiratory chain complexes
Mesh:
Substances:
Year: 2018 PMID: 29501406 DOI: 10.1016/j.braindev.2018.02.004
Source DB: PubMed Journal: Brain Dev ISSN: 0387-7604 Impact factor: 1.961